Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | Csnk1g3 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CSNK1G3 mRNA] | CTD | PMID:31150632 | 1,2-dichloroethane | decreases expression | EXP | | 6480464 | ethylene dichloride results in decreased expression of CSNK1G3 mRNA | CTD | PMID:28189721 and PMID:28960355 | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CSNK1G3 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | decreases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of CSNK1G3 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSNK1G3 mRNA | CTD | PMID:17942748 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CSNK1G3 mRNA | CTD | PMID:25210133 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | ESR1 protein promotes the reaction [Estradiol results in increased expression of CSNK1G3 mRNA] | CTD | PMID:25210133 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSNK1G3 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Csnk1g3 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CSNK1G3 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CSNK1G3 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CSNK1G3 mRNA | CTD | PMID:21354282 | 2,6-dinitrotoluene | affects expression | ISO | Csnk1g3 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of CSNK1G3 mRNA | CTD | PMID:21346803 | 2-ethoxyethanol | increases expression | ISO | Csnk1g3 (Rattus norvegicus) | 6480464 | 2-ethoxyethanol results in increased expression of CSNK1G3 mRNA | CTD | PMID:19643169 | 2-methylcholine | affects expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of CSNK1G3 mRNA | CTD | PMID:21179406 | 3,4-methylenedioxymethamphetamine | decreases expression | EXP | | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of CSNK1G3 mRNA | CTD | PMID:20188158 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Csnk1g3 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CSNK1G3 mRNA | CTD | PMID:36041667 | 4-hydroxyphenyl retinamide | increases expression | EXP | | 6480464 | Fenretinide results in increased expression of CSNK1G3 mRNA | CTD | PMID:28973697 | 5-aza-2'-deoxycytidine | decreases methylation | EXP | | 6480464 | Decitabine results in decreased methylation of CSNK1G3 gene | CTD | PMID:27923600 | 5-aza-2'-deoxycytidine | decreases expression | EXP | | 6480464 | Decitabine results in decreased expression of CSNK1G3 mRNA | CTD | PMID:27915011 | acrolein | multiple interactions | ISO | CSNK1G3 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CSNK1G3 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CSNK1G3 mRNA | CTD | PMID:32699268 | alpha-pinene | multiple interactions | ISO | CSNK1G3 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CSNK1G3 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CSNK1G3 mRNA | CTD | PMID:32699268 | ammonium chloride | affects expression | ISO | Csnk1g3 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of CSNK1G3 mRNA | CTD | PMID:16483693 | aristolochic acid A | decreases expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of CSNK1G3 mRNA | CTD | PMID:33212167 | arsenite(3-) | multiple interactions | ISO | CSNK1G3 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to CSNK1G3 mRNA] | CTD | PMID:32406909 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 and PMID:20018196 | bisphenol A | multiple interactions | ISO | CSNK1G3 (Homo sapiens) | 6480464 | [[ginger extract results in increased abundance of Oils and Volatile] which co-treated with bisphenol A] affects the expression of CSNK1G3 protein | CTD | PMID:33376534 | bisphenol A | multiple interactions | ISO | Csnk1g3 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CSNK1G3 mRNA | CTD | PMID:36041667 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CSNK1G3 mRNA | CTD | PMID:33221593 and PMID:38074096 | bisphenol F | multiple interactions | ISO | Csnk1g3 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CSNK1G3 mRNA | CTD | PMID:36041667 | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CSNK1G3 mRNA | CTD | PMID:37325564 | cadmium dichloride | increases expression | ISO | Csnk1g3 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased expression of CSNK1G3 mRNA | CTD | PMID:21297351 | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CSNK1G3 mRNA | CTD | PMID:37325564 | caffeine | decreases phosphorylation | ISO | CSNK1G3 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of CSNK1G3 protein | CTD | PMID:35688186 | calcium atom | affects expression | ISO | Csnk1g3 (Rattus norvegicus) | 6480464 | Calcium affects the expression of CSNK1G3 mRNA | CTD | PMID:15913539 | calcium(0) | affects expression | ISO | Csnk1g3 (Rattus norvegicus) | 6480464 | Calcium affects the expression of CSNK1G3 mRNA | CTD | PMID:15913539 | CGP 52608 | multiple interactions | ISO | CSNK1G3 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CSNK1G3 gene] | CTD | PMID:28238834 | copper(II) sulfate | increases expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of CSNK1G3 mRNA | CTD | PMID:19549813 | coumestrol | decreases expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | Coumestrol results in decreased expression of CSNK1G3 mRNA | CTD | PMID:19167446 | cyclosporin A | increases expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of CSNK1G3 mRNA | CTD | PMID:25562108 | dicrotophos | decreases expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of CSNK1G3 mRNA | CTD | PMID:28302478 | doxorubicin | decreases expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of CSNK1G3 mRNA | CTD | PMID:29803840 | epoxiconazole | decreases expression | EXP | | 6480464 | epoxiconazole results in decreased expression of CSNK1G3 mRNA | CTD | PMID:35436446 | fenvalerate | increases expression | ISO | Csnk1g3 (Rattus norvegicus) | 6480464 | fenvalerate results in increased expression of CSNK1G3 mRNA | CTD | PMID:30307764 | flutamide | increases expression | ISO | Csnk1g3 (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of CSNK1G3 mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CSNK1G3 mRNA | CTD | PMID:22206623 | FR900359 | increases phosphorylation | ISO | CSNK1G3 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of CSNK1G3 protein | CTD | PMID:37730182 | furan | increases expression | EXP | | 6480464 | furan results in increased expression of CSNK1G3 mRNA | CTD | PMID:24183702 | gentamycin | increases expression | ISO | Csnk1g3 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of CSNK1G3 mRNA | CTD | PMID:22061828 | leflunomide | increases expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | leflunomide results in increased expression of CSNK1G3 mRNA | CTD | PMID:28988120 | oxaliplatin | multiple interactions | ISO | Csnk1g3 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CSNK1G3 mRNA | CTD | PMID:25729387 | ozone | multiple interactions | ISO | CSNK1G3 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CSNK1G3 mRNA more ... | CTD | PMID:32699268 | resveratrol | multiple interactions | ISO | CSNK1G3 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of CSNK1G3 mRNA | CTD | PMID:23557933 | sodium fluoride | decreases expression | EXP | | 6480464 | Sodium Fluoride results in decreased expression of CSNK1G3 mRNA | CTD | PMID:21340527 | tetrachloromethane | increases expression | ISO | Csnk1g3 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of CSNK1G3 mRNA | CTD | PMID:31150632 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CSNK1G3 mRNA | CTD | PMID:31919559 | tetrachloromethane | multiple interactions | ISO | Csnk1g3 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CSNK1G3 mRNA] | CTD | PMID:31150632 | topotecan | multiple interactions | ISO | Csnk1g3 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CSNK1G3 mRNA | CTD | PMID:25729387 | topotecan | decreases expression | ISO | Csnk1g3 (Rattus norvegicus) | 6480464 | Topotecan results in decreased expression of CSNK1G3 mRNA | CTD | PMID:25729387 | troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of CSNK1G3 mRNA | CTD | PMID:28973697 | urethane | increases expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | Urethane results in increased expression of CSNK1G3 mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of CSNK1G3 mRNA | CTD | PMID:23179753 | vinclozolin | affects expression | ISO | Csnk1g3 (Rattus norvegicus) | 6480464 | vinclozolin affects the expression of CSNK1G3 mRNA | CTD | PMID:19015723 | vitamin E | decreases expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of CSNK1G3 mRNA | CTD | PMID:19244175 | |